TG Therapeutics, Inc.

$36.14
+0.44 (+1.24%)

Volume:

2.184K ($78.94K)

Market Capitalization:

$5.77B

TG Therapeutics Price Chart

TG Therapeutics Price Chart4:29 PM5:49 PM7:09 PM4:29 AM5:49 AM7:09 AM8:29 AM36.1636.0836.0135.9335.8535.7835.70

TG Therapeutics Volume Chart

TG Therapeutics Volume Chart4:29 PM5:49 PM7:09 PM4:29 AM5:49 AM7:09 AM8:29 AM831712594475356237119

TG Therapeutics Market Segments

Premarket

+0.44(+1.24%)
Open$35.70
Close$36.14
Low$35.70
Low Change0.00 (0.00%)
High$36.16
High Change+0.46 (+1.29%)
Range$0.46
Volume2.184K
Dollar Volume$78.94K

After Hours Yesterday

+0.29(+0.80%)
Open$35.71
Close$35.99
Low$35.71
Low Change0.00 (0.00%)
High$36.04
High Change+0.34 (+0.94%)
Range$0.34
Volume5.637K
Dollar Volume$202.88K

Regular Trading Hours Yesterday

+1.92(+5.68%)
Open$33.78
Close$35.70
Low$33.78
Low Change0.00 (0.00%)
High$36.08
High Change+2.30 (+6.81%)
Range$2.30
Volume1.706M
Dollar Volume$60.92M

Premarket Yesterday

-0.11(-0.32%)
Open$33.91
Close$33.80
Low$33.58
Low Change-0.33 (-0.97%)
High$33.91
High Change+0.00 (+0.00%)
Range$0.33
Volume3.065K
Dollar Volume$103.60K

TG Therapeutics Moving Averages

5 Day Moving Average (SMA5)$34.29
10 Day Moving Average (SMA10)$35.49
20 Day Moving Average (SMA20)$35.02
50 Day Moving Average (SMA50)$32.24
100 Day Moving Average (SMA100)$31.12
200 Day Moving Average (SMA200)$31.87

TG Therapeutics Statistics

Average Volume (30 Days)1.91M
P/E Ratio (Current)12.09
EPS (Current)$2.80
Dividend Yield0.00%
Free Cash Flow-$24.99M
Cash Ratio0.51
Current Ratio4.10
Quick Ratio3.29
Debt to Equity0.38
Enterprise Value$5.57B
EV to EBITDA45.16
EV to Sales9.04
Price to Book8.34
Price to Cash Flow
Price to Free Cash Flow
Price to Sales8.77
Return on Assets0.42%
Return on Equity0.69%

TG Therapeutics Stock Splits

There has been 1 stock split for TG Therapeutics (TGTX). The reverse stock split occured on April 30, 2012 and reduced the outstanding shares at a ratio of 56.25:1.

DateTypeRatio
Apr 30, 2012Reverse56.25:1

TG Therapeutics Dividends

There have been no dividends for TG Therapeutics (TGTX).